progenitor pool referred to as the second heart field (SHF). Here, we employ the zebrafish to investigate the molecular mechanisms responsible for selecting the correct number of SHF cells to build the OFT. Developmental timing assays have revealed that the zebrafish OFT is composed of late-differentiating cardiomyocytes. Gene expression patterns and time-lapse analysis suggest that these cells migrate into the heart from a region just adjacent to the arterial pole. Pharmacological antagonism of Fgf signaling depletes this population and inhibits OFT formation, but the effector genes downstream of Fgf signaling in this context are not well understood. To identify relevant effector genes, we analyzed the effects of loss of Fgf signaling on cardiac gene expression profiles. Intriguingly, we find that Fgf signaling acts to downregulate expression of cell adhesion molecule 4 (cadm4), which is normally expressed in and adjacent to the arterial pole. Strikingly, knockdown of cadm4 function causes a dramatic expansion of the OFT. In cadm4 morphants, a surplus of cells migrate into the arterial pole, ultimately resulting in the addition of nearly twice the normal number of late-differentiating OFT cardiomyocytes. Together, our results suggest a model in which Fgf signaling promotes the recruitment of the appropriate number of OFT cardiomyocytes by limiting cadm4 expression levels and thereby altering the cell adhesion properties of SHF-derived progenitors. Thus, we propose a novel adhesion-based mechanism for the regulation of cardiomyocyte differentiation, perturbation of which could be responsible for congenital defects in OFT formation. Two populations of cells, termed the first and second heart field, drive heart growth during chick and mouse development. The zebrafish has become a powerful model for vertebrate heart development, partly due to the evolutionary conservation of heart development pathways. Here we provide evidence that the zebrafish possesses an evolutionary conserved homolog to the murine second heart field. We developed a photoconversion assay to quantify the dynamic and gradual late addition of myocardial cells to the zebrafish arterial pole. We further show that late myocardial cells are derived from the same pre-gastrula embryonic region as early myocardial cells. We define an extra-cardiac region immediately posterior to the arterial pole, which we term the Interface Region. The Interface Region has cardiogenic properties, expressing myocardial markers such as vmhc and nkx2.5, but does not express a full complement of differentiated cardiomyocyte markers, lacking myl7 expression. We show that mef2cb, a zebrafish homolog of the mouse second heart field marker Mef2c, is expressed in the Interface Region, and is necessary for late myocardial addition to the arterial pole. FGF signaling after heart cone formation is necessary for mef2cb expression, the establishment of the Interface Region, and late myocardial addition to the arterial pole. Our study demonstrates that zebrafish heart growth shows more similarities to murine heart growth than previously thought. Further, as congenital heart disease is often associated with defects in second heart field development, the embryological and genetic advantages of the zebrafish model can be applied to study the vertebrate second heart field. Heart is one of the first organs to been formed in developing embryos and its formation requires spatial and temporal regulations of gene expression, however this regulation is poorly understood. Chromatin modifications are novel mechanisms for the regulation of gene expression. We study the enzyme Hdac9b, that compact the chromatin avoiding the binding of transcriptional factors to the DNA and silencing gene expression, and the transcriptional factor Hif1alpha, for its essential role in cardiovascular development. The role of Hdac9b and Hif-1alpha was studied by the injection of morpholino to hdac9b and/or hif-1alpha, at one cell stage and analyzed their effects in the expression of nkx2.5 and mef2c, two cardiogenic transcriptional factor. The fail of function of Hdac9b induced overexpression of nkx2.5 and mef2c and their expressions stands in time in a matter like the over expression or stabilization of Hif-1alpha, opposite effect was observed by the fail of function of Hif-1alpha. Additionally, EMSA shows an increased binding to the promoter of mef2c. The double fail of function of Hdac9b and Hif-1alpha down regulate cardiac genes, in a same way as the knockdown of Hif1alpha. These results suggest that Hdac9 could be a negative regulator of the function of Hif-1alpha in heart development, probably avoiding the access of this transcriptional factor to the DNA and repressing the expression of nkx2.5 and mef2c. Our results propose a new mechanism to explain the spatial and temporal gene regulations during cardiogenesis. Given the prevalence and severity of congenital heart disease, it is important to understand the mechanisms that underlie the proper development of the heart. While many regulators of cardiac development have been identified, few factors have been found which are important for the early steps in the formation of the cardiac lineage. The transcription factor Gata5 and chromatin re-modeling complex sub-unit Smarcd3b are able to direct non-cardiac cells to migrate and form part of the heart in the developing zebrafish embryo. These factors seem to be sufficient to replace all of the necessary signals required for heart development until after the completion of gastrulation. How Gata5 and Smarcd3b are able to confer this pro-cardiac activity may shed some light on the steps required for early cardiac progenitor development. Two technologies are being applied to facilitate the analysis of this activity. The first is the use of Ecdysone receptor fusion proteins in order to gain insight into the temporal requirements of the factors. The second is the use of a biotin ligase recognition peptide to facilitate the isolation of each protein in order to study their DNA binding sites. Constructs for each technology have been generated and the feasibility of each approach is currently being studied in vivo. The combination of these approaches will allow for the large scale study of downstream targets. 
